N.Y. Times
August 31, 2004
PERSONAL HEALTH
The Havoc of an Undetected Extra Chromosome
By JANE E. BRODY
Sam's parents began to suspect something was not quite right when at age
2, their son still was not walking and he said nothing that made any
sense.
Laboratory and neurological tests showed no abnormalities. But a genetic
test revealed that Sam's cells contained an extra copy of the X
chromosome. Instead of having 46 chromosomes, including one copy of each
of the sex chromosomes, X and Y, the normal complement for a boy, each of
Sam's cells had 47 chromosomes, with two X's and one Y, a genetic
abnormality commonly called Klinefelter's syndrome.
A doubling of the X chromosome, according to a government study of 40,000
infants in the 1970's, occurs once in every 500 to 1,000 male births,
making it one of the most common genetic abnormalities. It is a leading
genetic cause of male infertility. Yet nearly two-thirds of boys and men
who have Klinefelter's do not know it, and many live out their lives never
suspecting that they have an extra chromosome.
As Sam's mother noted in an interview, doctors, too, are often in the
dark. "None of our doctors had ever heard of it," she said. "We did a lot
of research on our own."
Sam is now 13, and through special education services, he has been able to
keep up academically. His speech is now normal and while he has had some
social problems, he loves sports and participates in athletics, his mother
said. As he enters puberty, his levels of testosterone are being checked
regularly by an endocrinologist. When they begin to drop below normal, he
will receive regular testosterone treatments.
Array of Symptoms
The syndrome was first identified in 1942 by Dr. Harry Klinefelter and
colleagues at Massachusetts General Hospital in Boston, and its genetic
root was discovered in the late 1950's. Dr. Klinefelter described symptoms
that included enlarged breasts, small testes, sparse facial and body hair
and an inability to produce sperm.
Later studies revealed other common complaints: delayed speech and motor
development; difficulty learning to read and write; very long legs; a
rounded body type; decreased muscle mass; a tendency to become overweight;
an increased risk of diabetes and osteoporosis; a small penis; and,
eventually, a loss of potency.
While overall intellectual abilities are not affected (the I.Q. scores of
people with Klinefelter's are only slightly lower than average), XXY males
often experience deficits in specific cognitive functions, including
language, concept formation, and problem solving, that are similar to
those in dyslexic children.
After age 25, about 70 percent of patients complain of decreasing libido
and potency, and normal beard growth is present in only about a fifth of
patients, wrote Dr. Fabio Lanfranco, and colleagues at the Institute of
Reproductive Medicine at the University of Münster in Germany, in a recent
article in the journal The Lancet.
Depression, difficulty following through on goals, unusual fatigue and
sudden mood swings also often occur in XXY men and boys. There is,
however, no increase in psychiatric disturbances, criminal behavior or
mental retardation.
Many of the symptoms of Klinefelter's, especially those noted at puberty
and beyond, result from a deficiency of testosterone, which occurs in
about 80 percent of XXY males after the age of 15. But the expression of
these symptoms varies widely, which accounts in part for why so many men
and boys with an extra X chromosome go undetected.
Once the genetic abnormality is diagnosed, many of the symptoms can be
reversed by regular testosterone treatments starting at puberty and
continuing for life, but failure of normal sperm production is not yet
correctable.
Today, the term Klinefelter's syndrome has fallen out of favor because its
expression is so varied, and most medical researchers now refer to
affected boys and men simply as XXY males. Genetic studies have also
revealed many variants of the chromosomal mishap. Some boys are born with
three or more X chromosomes and one Y, some with two X's and two Y's, and
some with a combination of normal XY cells and abnormal XXY cells. The
latter are called genetic mosaics, and they tend to have fewer symptoms
than boys with only XXY cells.
These unusual combinations most often result from problems during the
formation of the egg or sperm that result in a failure of the two sex
chromosomes in a germ cell to separate properly.
Treatment Can Help
Early recognition and treatment of Klinefelter's syndrome can
significantly improve the patient's quality of life and prevent serious
consequences, Dr. Lanfranco and his team wrote. When testosterone levels
are low, they said, replacement therapy should be started as early as
possible. This results in increased masculinity, strength, libido, bone
mineral density and body hair. It also has a positive effect on mood and
behavior, improves goal-directed thinking and self-esteem and reduces
fatigue and irritability.
Testosterone therapy is also beneficial to the cardiovascular system,
though it has no effect on fertility. For Klinefelter patients with
bothersome breast development, surgical removal of excess tissue is
possible.
But long before testosterone replacement is needed, XXY boys can benefit
from special education classes, speech therapy and social behavior
training. For those seeking a solution to their infertility, it is now
possible in some cases to extract sperm directly from the testes and
insert them into an egg outside the woman's body. After fertilization and
early embryonic development, the embryos can be checked to be sure they
too do not contain the XXY defect before inserting them into the womb. One
expert has reported a live birth rate of 20 percent following this
procedure in 20 couples affected by XXY infertility.
Melissa Aylstock, the mother of an XXY boy and founder of KS & Associates,
publishes a newsletter with information about support groups. The
organization can be reached by writing to 11 Keats Court, Coto de Caza,
Calif. 92679, or calling toll-free (888) 999-9428. Its Web site is
Copyright 2004 The New York Times Company